Skip to main content
Caplight Logo









ALKemist Bio

ALKemist Bio

Private
TurinHealthcare & Life Scienceshttps://www.alkemistbio.com/

Last Round

Seed

Dec 21, 2023

Total Funding Raised

$7.56M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

ALKemist Bio is a biotechnology company developing T-cell receptor (TCR-T) cell therapies for ALK-positive cancers.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

cellular immunotherapyCAR-T therapyTCR-T therapyadoptive cell therapyautologous cell therapyimmuno-oncologyALK-positive cancerALK targeted therapynon-small cell lung cancerNSCLCneuroblastomagene therapytreatment-resistant cancerpreclinical biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ALKemist Bio Comparables

Compare ALKemist Bio with similar companies based on industry and business-model similarity.

ALKemist Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Captain T Cell GmbH
78%
PersonGen BioTherapeutics
67%
Anocca
66%

ALKemist Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedDec 21, 2023

ALKemist Bio Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors grew 93% MoM.

  • May 15, 2026

    Monthly visitors increased 2217% MoM, reaching 1.5K.

ALKemist Bio Filings

Explore SEC and related filing metadata, where available.

ALKemist Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about ALKemist Bio's valuation, stock price, and market status.

Is ALKemist Bio a public or private company?

ALKemist Bio is a private company.

What is the current stock price of ALKemist Bio?

ALKemist Bio is a private company with no public stock price. No recent secondary market data is available.

How much is ALKemist Bio worth (valuation)?

Valuation information for ALKemist Bio is not publicly available.

Can I buy ALKemist Bio stock?

ALKemist Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was ALKemist Bio's last funding round?

ALKemist Bio's most recent funding round was Seed on December 21, 2023.

Who are the main investors in ALKemist Bio?

Key investors in ALKemist Bio include Claris Ventures.

Will ALKemist Bio IPO soon?

No public IPO plans have been announced for ALKemist Bio.

How can I track ALKemist Bio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ALKemist Bio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersTurin
Employee Range6
Year Founded2023
Last FundingDec 21, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?